Computer Tomography (CT)-based Screening of Hospitalized Patients with Chronic Obstructive Pulmonary Disease Complicated by Bronchiectasis Phenotype during Acute Exacerbation: A Clinical Analysis

Article ID: e080523216632 Pages: 6

  • * (Excluding Mailing and Handling)

Abstract

Background: In the past, many experts considered chronic obstructive pulmonary disease (COPD) and bronchiectasis to be separate, chronic respiratory diseases. Nonetheless, the widespread use of high-resolution lung computed tomography (CT) has led to the discovery that these diseases can occur alone or together.

Aim: The current study aimed to compare the effects of nutritional status on the clinical outcomes in moderate to severe COPD patients with bronchiectasis.

Objective: This study identifies the nutritional risk in hospitalized patients with moderate to severe COPD complicated by bronchiectasis phenotype during acute exacerbation screened using computer tomography (CT). Also, determines its correlation with disease progression.

Materials and Methods: NRS 2002 (Nutrition Risk Screening Evaluation Tool) was used to determine and evaluate the nutritional risk status in 182 hospitalized patients with moderate to severe COPD complicated by bronchiectasis phenotype during an acute exacerbation. Selected patients were divided into the nutritional risk (NR) group and the non-nutritional risk (NNR) group according to their nutritional status determined by NRS 2002. The body mass index (BMI), serum albumin (ALB), pre albumin (PAB), lymphocyte count (TLC), FEV1/FVC, FEV1% predicted, PEF% predicted, blood gas analysis, number of acute exacerbations in the past year, number of respiratory failure cases, number of anti-infection days, and length of hospitalization of the two groups were observed.

Results: The hospitalized patients in acute exacerbation of moderate to severe COPD complicated by bronchiectasis phenotype had a nutritional risk of 62.64%. BMI, ALB, PAB, TLC, FEV1% predicted, FEV1/FVC, PEF% predicted, blood gas analysis, number of acute exacerbations in the past year, number of respiratory failure cases, number of anti-infection days, and length of hospitalization were statistically significantly different between the NR group and NNR group (P<0.05).

Conclusion: Hospitalized patients with moderate to severe COPD complicated by bronchiectasis phenotype during acute exacerbation are often associated with nutritional risk. An increase in nutritional risk reduces the level of pulmonary function of the patient and elevates the risk for repeated acute exacerbations, which predispose the patient to respiratory failure, thereby increasing the length of hospitalization. Therefore, the nutritional risk status of COPD patients with bronchiectasis was closely related to the occurrence, development, and prognosis of the disease.

[1]
Adeloye D, Agarwal D, Barnes PJ, et al. Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade. J Glob Health 2021; 11: 15003.
[http://dx.doi.org/10.7189/jogh.11.15003] [PMID: 34737870]
[2]
Scoditti E, Massaro M, Garbarino S, Toraldo DM. Role of diet in chronic obstructive pulmonary disease prevention and treatment. Nutrients 2019; 11(6): 1357.
[http://dx.doi.org/10.3390/nu11061357] [PMID: 31208151]
[3]
Pleasants RA, Heidari K, Wheaton AG, et al. Targeting persons with or at high risk for chronic obstructive pulmonary disease by state-based surveillance. COPD 2015; 12(6): 680-9.
[http://dx.doi.org/10.3109/15412555.2015.1043424] [PMID: 26367193]
[4]
Zhang K, Zou X, Ma Z, et al. Risk factors associated with impairment in pulmonary diffusing capacity among patients with noncystic fibrosis bronchiectasis. Can Respir J 2022; 2022: 1-10.
[http://dx.doi.org/10.1155/2022/8175508] [PMID: 35308822]
[5]
Dou L, Wang X, Cao Y, Hu A, Li L. Relationship between postoperative recovery and nutrition risk screened by NRS 2002 and nutrition support status in patients with gastrointestinal cancer. Nutrition and Cancer 2020; 72(1): 33-40.
[http://dx.doi.org/10.1080/01635581.2019.1612927]
[6]
Dou S, Zheng C, Cui L, et al. High prevalence of bronchiectasis in emphysema-predominant COPD patients. Int J Chron Obstruct Pulmon Dis 2018; 13: 2041-7.
[http://dx.doi.org/10.2147/COPD.S163243] [PMID: 29988718]
[7]
MacNee W. Pathology, pathogenesis, and pathophysiology. BMJ 2006; 332(7551): 1202-4.
[http://dx.doi.org/10.1136/bmj.332.7551.1202]
[8]
Martinez-Garcia MA, Miravitlles M. Bronchiectasis in COPD patients: More than a comorbidity? Int J Chron Obstruct Pulmon Dis 2017; 12: 1401-11.
[http://dx.doi.org/10.2147/COPD.S132961] [PMID: 28546748]
[9]
MacLeod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact. Respirology 2021; 26(6): 532-51.
[http://dx.doi.org/10.1111/resp.14041] [PMID: 33893708]
[10]
Jian W, Zeng H, Zhang X, et al. Clinical characteristics of patients with chronic obstructive pulmonary disease assessed using GOLD 2016 and GOLD 2018 classifications: A cross-sectional study in China. J Thorac Dis 2021; 13(10): 5701-16.
[http://dx.doi.org/10.21037/jtd-21-255] [PMID: 34795920]
[11]
Polverino E, Dimakou K, Hurst J, et al. The overlap between bronchiectasis and chronic airway diseases: State of the art and future directions. Eur Respir J 2018; 52(3): 1800328.
[http://dx.doi.org/10.1183/13993003.00328-2018] [PMID: 30049739]
[12]
Roca M, Verduri A, Corbetta L, Clini E, Fabbri LM, Beghé B. Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease. Eur J Clin Invest 2013; 43(5): 510-21.
[http://dx.doi.org/10.1111/eci.12064] [PMID: 23489139]
[13]
Ostridge K, Wilkinson TMA. Present and future utility of computed tomography scanning in the assessment and management of COPD. Eur Respir J 2016; 48(1): 216-28.
[http://dx.doi.org/10.1183/13993003.00041-2016] [PMID: 27230448]
[14]
Lee YK, Oh YM, Lee JH, et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008; 186(3): 157-65.
[http://dx.doi.org/10.1007/s00408-008-9071-0] [PMID: 18351420]
[15]
Schwegler I, von Holzen A, Gutzwiller J-P, Schlumpf R, Mühlebach S, Stanga Z. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg 2009; 97(1): 92-7.
[http://dx.doi.org/10.1002/bjs.6805] [PMID: 20013933]
[16]
Reber E, Gomes F, Vasiloglou MF, Schuetz P, Stanga Z. Nutritional risk screening and assessment. J Clin Med 2019; 8(7): 1065.
[http://dx.doi.org/10.3390/jcm8071065] [PMID: 31330781]
[17]
Hancu A. Nutritional status as a risk factor in COPD. Maedica 2019; 14(2): 140-3.
[http://dx.doi.org/10.26574/maedica.2019.14.2.140] [PMID: 31523295]
[18]
Ni Y, Shi G, Yu Y, Hao J, Chen T, Song H. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: A systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2015; 10: 1465-75.
[http://dx.doi.org/10.2147/COPD.S83910] [PMID: 26251586]
[19]
Bchir S, Nasr H, Bouchet S, et al. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease. J Cell Mol Med 2017; 21(7): 1280-91.
[http://dx.doi.org/10.1111/jcmm.13057] [PMID: 28004483]
[20]
Gramegna A, Amati F, Terranova L, et al. Neutrophil elastase in bronchiectasis. Respir Res 2017; 18(1): 211.
[http://dx.doi.org/10.1186/s12931-017-0691-x] [PMID: 29258516]
[21]
Mukhopadhyay A, Henry J, Ong V, et al. Association of modified NUTRIC score with 28-day mortality in critically ill patients. Clin Nutr 2017; 36(4): 1143-8.
[http://dx.doi.org/10.1016/j.clnu.2016.08.004] [PMID: 27582120]
[22]
Zhang R, Lu H, Chang Y, Zhang X, Zhao J, Li X. Prediction of 30-day risk of acute exacerbation of readmission in elderly patients with COPD based on support vector machine model. BMC Pulm Med 2022; 22(1): 292.
[http://dx.doi.org/10.1186/s12890-022-02085-w] [PMID: 35907836]
[23]
Hallin R, Koivisto-Hursti UK, Lindberg E, Janson C. Nutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Respir Med 2006; 100(3): 561-7.
[http://dx.doi.org/10.1016/j.rmed.2005.05.020] [PMID: 16019198]
[24]
Planas M, Álvarez J, García-Peris PA, et al. Nutritional support and quality of life in stable chronic obstructive pulmonary disease (COPD) patients. Clin Nutr 2005; 24(3): 433-41.
[http://dx.doi.org/10.1016/j.clnu.2005.01.005] [PMID: 15896431]
[25]
Posłuszna D, Doboszyńska A. Evaluation of the nutritional status in patients with chronic obstructive pulmonary disease (COPD) and the impact of diet on the risk of its occurrence [Assessment of nutritional status of patients with chronic obstructive pulmonary disease (COPD) and the impact of diet on COPD risk]. Pneumonol Alergol Pol 2011; 79(2): 109-5.
[26]
Heyland DK, Dhaliwal R, Wang M, Day AG. The prevalence of iatrogenic underfeeding in the nutritionally ‘at-risk’ critically ill patient: Results of an international, multicenter, prospective study. Clin Nutr 2015; 34(4): 659-66.
[http://dx.doi.org/10.1016/j.clnu.2014.07.008] [PMID: 25086472]
[27]
Chen H, Wang S, Zhao Y, Luo Y, Tong H, Su L. Correlation analysis of omega-3 fatty acids and mortality of sepsis and sepsis-induced ARDS in adults: Data from previous randomized controlled trials. Nutr J 2018; 17(1): 57.
[http://dx.doi.org/10.1186/s12937-018-0356-8] [PMID: 29859104]
[28]
Chung WS, Lin CL. Acute respiratory events in patients with bronchiectasis–COPD overlap syndrome: A population-based cohort study. Respir Med 2018; 140: 6-10.
[http://dx.doi.org/10.1016/j.rmed.2018.05.008] [PMID: 29957282]
[29]
Holst M, Beck AM, Rasmussen HH, Lange P. Insufficient intake of energy and protein is related to physical functional capacity among COPD patients referred to municipality based pulmonary rehabilitation. Clin Nutr ESPEN 2019; 30: 35-41.
[http://dx.doi.org/10.1016/j.clnesp.2019.02.009] [PMID: 30904227]